Issue of Equity

Summary by AI ^BETAClose X

Unicorn AIM VCT plc has announced the allotment of 1,356,094 Ordinary Shares at 83.9 pence per share, issued under the Dividend Reinvestment Scheme for the final dividend of the year ending 30 September 2025. These new shares, with dealings expected to commence around 16 February 2026, bring the company's total issued share capital and voting rights to 216,637,138 Ordinary Shares. This updated figure serves as the denominator for shareholders to determine notification requirements under the FCA's Disclosure and Transparency Rules.

Disclaimer*

Unicorn AIM VCT PLC

13 February 2026

Unicorn AIM VCT plc

LEI: 21380057QDV7D34E9870

13 February 2026

Issue of Equity and Total Voting Rights

Unicorn AIM VCT plc (the "Company") announces the allotment of 1,356,094 Ordinary Shares of 1p each at a price of 83.9 pence per share, being the latest published net asset value per share at 31 January 2026, to Shareholders who elected to receive Ordinary Shares under the Dividend Reinvestment Scheme as an alternative to cash in respect of the Final Dividend for the year ending 30 September 2025.

Application for the new shares to be admitted to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities has been made and dealings are expected to commence on or around 16 February 2026.

The issued share capital and total voting rights of the Company is now 216,637,138 Ordinary Shares.

The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Unicorn AIM VCT plc under the FCA's Disclosure and Transparency Rules.

For further information please contact:

ISCA Administration Services Limited,

Company Secretary 01392 487056

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END